Vonicog Alfa, Recombinant human VWF

The product is indicated for the on-demand treatment and control of bleeding episodes in adults previously diagnosed with von Willebrand disease. The product contains only the vWF and thus, its administration offers the flexibility to administer the coagulation factor VIII if needed. The von Willebrand disease is an inherited disorder characterized by the deficiency or misfunction of the von Willebrand factor (vWF). Due to this deficiency, the blood cannot clot properly and the patients that present this disease are prone to prolonged or excessive bleeding. There are three types of this disease, and type 3 is an autosomal recessive inherited disorder marked by very low or absent levels of vWF.

Store it under sterile conditions at -20 to-70°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

Vonicog Alfa, Recombinant human VWF